Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. - Wikidata - wikimedia - TriplyDB

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

http://www.wikidata.org/entity/Q34538916

about

Molecular action of methotrexate in inflammatory diseases Regulation of neutrophil function by adenosine.Low-dose adenosine stress echocardiography: detection of myocardial viability A2B adenosine receptor activity is reduced in neutrophils from patients with systemic sclerosis Adenosine A(2A) Receptor Antagonists and Parkinson's Disease Effect of endothelial cells on phagocyte-mediated anticryptococcal activity It is time to ask what adenosine can do for cardioprotection.The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.Adenosine therapy: a new approach to chronic heart failure.Adenosine and chronic ischemia of the lower limbs.Purine catabolism in polymorphonuclear neutrophils. Phorbol myristate acetate-induced accumulation of adenosine owing to inactivation of extracellularly released adenosine deaminase.Soluble mediators regulating immunity in early life The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively Roles of the adenosine receptor and CD73 in the regulatory effect of γδ T cells.Adenosine in fibrosis.Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis Effects of adenosine on the functions of circulating polymorphonuclear leukocytes during hyperdynamic endotoxemia.Xanthine oxidase-derived hydrogen peroxide contributes to ischemia reperfusion-induced edema in gerbil brains Cultured human endothelial cells stimulated with cytokines or endotoxin produce an inhibitor of leukocyte adhesion.Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical Attenuation of anti-Thy1 glomerulonephritis in the rat by anti-inflammatory platelet-inhibiting agents.Adenosine: a prototherapeutic concept in neurodegeneration.Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing.Adenosine promotes neutrophil chemotaxis.Neutrophil-derived 5'-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation A2B adenosine receptor activation switches differentiation of bone marrow cells to a CD11c(+)Gr-1(+) dendritic cell subset that promotes the Th17 response.Activation of adenosine receptor on gingival fibroblasts Recurrent infections and immune evasion strategies of Staphylococcus aureus.Release of adenosine from human neutrophils stimulated by platelet activating factor, leukotriene B(4) and opsonized zymosan.Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion.Regulation of inflammation by adenosine.Adenosine and anergy.The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation.Soluble ecto-5'-nucleotidase (5'-NT), alkaline phosphatase, and adenosine deaminase (ADA1) activities in neonatal blood favor elevated extracellular adenosine.Reduced ligand affinity leads to an impaired function of the adenosine A2A receptor of human granulocytes in sepsis Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.Staphylococcus aureus synthesizes adenosine to escape host immune responses Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.Mechanisms underlying methotrexate-induced pulmonary toxicity.St Cyres lecture. Endothelium in control.

P2860

Q24534771-AF1E624F-4121-4774-A8F4-3B60B81F3525 Q24620317-FA4A5667-6B73-452B-9BEC-1D14047804E8 Q24802516-F7C21773-8767-4E1A-A684-534A6DCDEC6A Q24803585-4111FFE4-294B-4D0C-8C8C-68D393D814C9 Q29346492-0FFADFA7-31FB-4512-B2B1-B954E9154465 Q33608093-F4BC36B4-F2E0-4D66-A7D5-10F9E9A0972C Q33731467-FAB96197-2941-444A-A73C-5D7F13E5AADE Q33909650-0B2DF807-CA5A-4CE1-AFF0-4E6A6970572E Q34075147-A6A0C620-C56C-4E6B-ADAF-553852AB0B0C Q34158939-4424D322-E61A-4660-AFB4-4615C0698EC8 Q34177973-AF789660-290F-4615-AE43-D45F84314587 Q34238426-841B4349-ECF5-4486-9D29-A09F71019562 Q34248005-408C43F8-BAF7-498B-BDA5-191AE67099A1 Q34277485-71B1DE9D-23CE-4E95-9A9F-E44811C57FA5 Q35085245-0E8CE12D-80DB-4C0C-AEFC-278DD4617900 Q35546429-0F9A26DA-D41F-46D6-AB44-7537E116507B Q35548816-45B1BEAC-A3C2-4258-A710-1F5E3F5AD1DC Q35588384-A3283048-D63B-4AC7-B68A-3AC72D1F660C Q35591127-95AD554A-BA27-4FEB-90D0-34C8F8C53B35 Q35811212-1B68A806-4738-46E7-BC26-F16033CF941E Q35832265-502CD8C2-924B-43E7-8A4A-E00956F910DF Q36219758-025F66CC-D500-4225-AE04-6759A75F32E9 Q36289418-EC6D06C3-F99D-450B-917E-D2661F97BAFA Q36354651-BE3E48F1-AE1E-4F65-94A9-9E005B3946FD Q36404222-2E23039C-5274-4DF2-9D3E-65DBD6D6F099 Q36410586-EB8985B1-C9CB-453F-95F7-E186704C248B Q36427173-DE76BFEB-2ADB-494A-A010-867D28695940 Q36513761-B10172CC-560B-4462-BDA7-FFB59CC24B9F Q36626982-D3BD65BB-ECF3-4539-AFFB-60471882BF16 Q36738131-9B66E1EF-6E76-49B8-90CB-6EAFA902702A Q36746981-38A1C955-3E1D-45BE-BC83-DE8CDF2B17E4 Q36922986-B9C96E27-7BE1-468F-8745-4A593D6F2712 Q36993161-FBAE5215-8E61-40D0-923F-65CDD8D85010 Q37189501-820BBD0D-344F-4DCF-AF44-0B652D449CD7 Q37296188-E49904FD-B785-4AFC-B44E-2738B8E94B82 Q37383893-20AB6979-D5A7-4DF4-A662-020E72D89DCA Q37402368-9DD06D84-D54E-4872-9BB8-7E3E7771128D Q37443977-B6EDA40E-D9FC-4DA7-A295-8813C93DF49D Q37524010-9A76B5B6-5DCF-45E2-A6E1-2A23D746245A Q37691303-99F96DD2-932A-4216-80F3-559EB14631D9

P2860

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

http://www.wikidata.org/entity/Q34538916

description

1986 nî lūn-bûn

@nan

1986 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1986 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1986年の論文

@ja

1986年論文

@yue

1986年論文

@zh-hant

1986年論文

@zh-hk

1986年論文

@zh-mo

1986年論文

@zh-tw

1986年论文

@wuu

name

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

@ast

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

@en

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

@nl

type

label

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

@ast

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

@en

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

@nl

prefLabel

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

@ast

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

@en

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

@nl

P1433

Q34538916-39FF05B5-D43C-490E-8BF2-5BEDF8EB45AC

P1476

Q34538916-5EAC9AE0-19CC-47E1-9735-F4FCBB5D6B12

P2093

Q34538916-87555662-00ED-4B78-8DDC-7A2A325B0725

Q34538916-A3782254-4E79-4B8F-9B5E-7C2A710FA897

Q34538916-B240DB7E-C61A-4A93-A085-4DE41F3313DE

Q34538916-C8C071BD-596A-4DA3-834F-730A1393EB1B

Q34538916-F16EF554-3C52-4997-8C87-72EBEEBAE647

P2860

Q34538916-0995EE7E-70C1-4B24-863B-0844F5E3F9D4

Q34538916-09C55C4A-966F-468D-8070-11F2C85EB95D

Q34538916-0A2DF1CA-14C4-4B24-9A0D-F2B9B6FF504F

Q34538916-1656C468-4BA1-470C-AB06-0C05DC990FB1

Q34538916-168C908B-383F-4D8E-830F-553D47831F85

Q34538916-1B880DC2-5D19-4A5A-B185-4550B7532CBA

Q34538916-3374A0DA-F110-4C0D-AD8F-DC9D40DAC2DA

Q34538916-3B258A41-88C7-4EFB-AD79-8EE772127D96

Q34538916-59938236-BE5D-434D-B0F5-5693081341DF

Q34538916-676BE887-9FD3-497C-85FE-2D2DAD54BE6D

P304

Q34538916-20164C4E-F6E3-4E3A-BF7F-5EEEAF6EE750

P31

Q34538916-7528078B-0D10-475D-B32D-129D115FFEE5

P356

Q34538916-B2D15E3B-1583-4F5F-B5AE-182FBDEF3A7F

P407

Q34538916-6F95A457-B5CD-4CDF-AB59-13FA79B3B928

P433

Q34538916-42717171-734D-4875-857A-FFF5C3DB8BB8

P478

Q34538916-4FD16E4C-C1EC-40A4-9064-AE95F2BE61ED

P577

Q34538916-2B8CBB5A-BC11-4159-B674-2185A5301B0C

P698

Q34538916-3D73B2E9-2781-46A6-B848-D633D0B336C7

P921

Q34538916-66EDC587-B42E-4A07-A89D-FE36957AFEB6

P932

Q34538916-7B42C4FC-541B-4C68-8A87-12228972D34A

P356

P1433

Journal of Clinical Investigation

P1476

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

@en

P2093

B N Cronstein

http://www.w3.org/2001/XMLSchema#string

G Weissmann

http://www.w3.org/2001/XMLSchema#string

J Belanoff

http://www.w3.org/2001/XMLSchema#string

R Hirschhorn

http://www.w3.org/2001/XMLSchema#string

R I Levin

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g

Chemotactic activity in the coronary sinus after experimental myocardial infarction: effects of pharmacologic interventions on ischemic injury

Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase

Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

Release of adenosine from human hearts during angina induced by rapid atrial pacing.

Antiadhesive properties of biological surfaces are protective against stimulated granulocytes

Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro.

A quantitative assay for intercellular adhesion.

Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide.

P304

760-770

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI112638

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

1986-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3745437

http://www.w3.org/2001/XMLSchema#string

P921

P932

423670

http://www.w3.org/2001/XMLSchema#string